6 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - ... #Tuberculosis ... #medications #pharmacology ... #Treatment
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Resistant Tuberculosis ... #pharmacology # ... dosing #idsa #drugs
Cavitary Lesion with Air-Fluid Level on Chest XRay

70+ year old man with PMH of latent TB
PMH of latent TB ... s/p treatment and ... #Cavitary #CXR ... #ChestXRay #Clinical ... #Pulmonary #Radiology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... and Culture • CXR ... Treatment: Active ... disease • Check CXR ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... and Culture • CXR ... Treatment: Active ... disease • Check CXR ... #Management #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... RAL-based ART regimen ... HIV-infected persons with clinical ... #TB #IDSA #Prevention ... infections #HIVAIDS #pharmacology